Global Cancer Vaccine Market Research Report 2022(Status and Outlook)

June 2022 | 100 pages | ID: GA10BBA2A242EN
Bosson Research

Abstracts

Report Overview

The Global Cancer Vaccine Market Size was estimated at USD 5844.12 million in 2021 and is projected to reach USD 23945.63 million by 2028, exhibiting a CAGR of 22.32% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Cancer Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cancer Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cancer Vaccine market in any manner.

Global Cancer Vaccine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Dendreon Corporation
• NeoStem Oncology
• ImmunoGen
• Inovio Pharmaceuticals
• Novartis

Market Segmentation (by Type)

• Preventive Vaccines
• Therapeutic Vaccines

Market Segmentation (by Application)

• Prostate Cancer
• Cervical Cancer
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Cancer Vaccine Market
• Overview of the regional outlook of the Cancer Vaccine Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Vaccine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Cancer Vaccine
1.2 Key Market Segments
  1.2.1 Cancer Vaccine Segment by Type
  1.2.2 Cancer Vaccine Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 CANCER VACCINE MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Cancer Vaccine Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Cancer Vaccine Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 CANCER VACCINE MARKET COMPETITIVE LANDSCAPE

3.1 Global Cancer Vaccine Sales by Manufacturers (2017-2022)
3.2 Global Cancer Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.3 Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cancer Vaccine Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Cancer Vaccine Sales Sites, Area Served, Product Type
3.6 Cancer Vaccine Market Competitive Situation and Trends
  3.6.1 Cancer Vaccine Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Cancer Vaccine Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 CANCER VACCINE INDUSTRY CHAIN ANALYSIS

4.1 Cancer Vaccine Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF CANCER VACCINE MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 CANCER VACCINE MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Vaccine Sales Market Share by Type (2017-2022)
6.3 Global Cancer Vaccine Market Size Market Share by Type (2017-2022)
6.4 Global Cancer Vaccine Price by Type (2017-2022)

7 CANCER VACCINE MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Vaccine Market Sales by Application (2017-2022)
7.3 Global Cancer Vaccine Market Size (M USD) by Application (2017-2022)
7.4 Global Cancer Vaccine Sales Growth Rate by Application (2017-2022)

8 CANCER VACCINE MARKET SEGMENTATION BY REGION

8.1 Global Cancer Vaccine Sales by Region
  8.1.1 Global Cancer Vaccine Sales by Region
  8.1.2 Global Cancer Vaccine Sales Market Share by Region
8.2 North America
  8.2.1 North America Cancer Vaccine Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Cancer Vaccine Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Cancer Vaccine Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Cancer Vaccine Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Cancer Vaccine Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 Dendreon Corporation
  9.1.1 Dendreon Corporation Cancer Vaccine Basic Information
  9.1.2 Dendreon Corporation Cancer Vaccine Product Overview
  9.1.3 Dendreon Corporation Cancer Vaccine Product Market Performance
  9.1.4 Dendreon Corporation Business Overview
  9.1.5 Dendreon Corporation Cancer Vaccine SWOT Analysis
  9.1.6 Dendreon Corporation Recent Developments
9.2 NeoStem Oncology
  9.2.1 NeoStem Oncology Cancer Vaccine Basic Information
  9.2.2 NeoStem Oncology Cancer Vaccine Product Overview
  9.2.3 NeoStem Oncology Cancer Vaccine Product Market Performance
  9.2.4 NeoStem Oncology Business Overview
  9.2.5 NeoStem Oncology Cancer Vaccine SWOT Analysis
  9.2.6 NeoStem Oncology Recent Developments
9.3 ImmunoGen
  9.3.1 ImmunoGen Cancer Vaccine Basic Information
  9.3.2 ImmunoGen Cancer Vaccine Product Overview
  9.3.3 ImmunoGen Cancer Vaccine Product Market Performance
  9.3.4 ImmunoGen Business Overview
  9.3.5 ImmunoGen Cancer Vaccine SWOT Analysis
  9.3.6 ImmunoGen Recent Developments
9.4 Inovio Pharmaceuticals
  9.4.1 Inovio Pharmaceuticals Cancer Vaccine Basic Information
  9.4.2 Inovio Pharmaceuticals Cancer Vaccine Product Overview
  9.4.3 Inovio Pharmaceuticals Cancer Vaccine Product Market Performance
  9.4.4 Inovio Pharmaceuticals Business Overview
  9.4.5 Inovio Pharmaceuticals Cancer Vaccine SWOT Analysis
  9.4.6 Inovio Pharmaceuticals Recent Developments
9.5 Novartis
  9.5.1 Novartis Cancer Vaccine Basic Information
  9.5.2 Novartis Cancer Vaccine Product Overview
  9.5.3 Novartis Cancer Vaccine Product Market Performance
  9.5.4 Novartis Business Overview
  9.5.5 Novartis Cancer Vaccine SWOT Analysis
  9.5.6 Novartis Recent Developments

10 CANCER VACCINE MARKET FORECAST BY REGION

10.1 Global Cancer Vaccine Market Size Forecast
10.2 Global Cancer Vaccine Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Cancer Vaccine Market Size Forecast by Country
  10.2.3 Asia Pacific Cancer Vaccine Market Size Forecast by Region
  10.2.4 South America Cancer Vaccine Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Cancer Vaccine by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Cancer Vaccine Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Cancer Vaccine by Type (2022-2028)
  11.1.2 Global Cancer Vaccine Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Cancer Vaccine by Type (2022-2028)
11.2 Global Cancer Vaccine Market Forecast by Application (2022-2028)
  11.2.1 Global Cancer Vaccine Sales (K Units) Forecast by Application
  11.2.2 Global Cancer Vaccine Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cancer Vaccine Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Cancer Vaccine Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Cancer Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Cancer Vaccine Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Cancer Vaccine Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Vaccine as of 2021)
Table 10. Global Market Cancer Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Cancer Vaccine Sales Sites and Area Served
Table 12. Manufacturers Cancer Vaccine Product Type
Table 13. Global Cancer Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cancer Vaccine
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cancer Vaccine Market Challenges
Table 22. Market Restraints
Table 23. Global Cancer Vaccine Sales by Type (K Units)
Table 24. Global Cancer Vaccine Market Size by Type (M USD)
Table 25. Global Cancer Vaccine Sales (K Units) by Type (2017-2022)
Table 26. Global Cancer Vaccine Sales Market Share by Type (2017-2022)
Table 27. Global Cancer Vaccine Market Size (M USD) by Type (2017-2022)
Table 28. Global Cancer Vaccine Market Size Share by Type (2017-2022)
Table 29. Global Cancer Vaccine Price (USD/Unit) by Type (2017-2022)
Table 30. Global Cancer Vaccine Sales (K Units) by Application
Table 31. Global Cancer Vaccine Market Size by Application
Table 32. Global Cancer Vaccine Sales by Application (2017-2022) & (K Units)
Table 33. Global Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 34. Global Cancer Vaccine Sales by Application (2017-2022) & (M USD)
Table 35. Global Cancer Vaccine Market Share by Application (2017-2022)
Table 36. Global Cancer Vaccine Sales Growth Rate by Application (2017-2022)
Table 37. Global Cancer Vaccine Sales by Region (2017-2022) & (K Units)
Table 38. Global Cancer Vaccine Sales Market Share by Region (2017-2022)
Table 39. North America Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 40. Europe Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Cancer Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. South America Cancer Vaccine Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Cancer Vaccine Sales by Region (2017-2022) & (K Units)
Table 44. Dendreon Corporation Cancer Vaccine Basic Information
Table 45. Dendreon Corporation Cancer Vaccine Product Overview
Table 46. Dendreon Corporation Cancer Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Dendreon Corporation Business Overview
Table 48. Dendreon Corporation Cancer Vaccine SWOT Analysis
Table 49. Dendreon Corporation Recent Developments
Table 50. NeoStem Oncology Cancer Vaccine Basic Information
Table 51. NeoStem Oncology Cancer Vaccine Product Overview
Table 52. NeoStem Oncology Cancer Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. NeoStem Oncology Business Overview
Table 54. NeoStem Oncology Cancer Vaccine SWOT Analysis
Table 55. NeoStem Oncology Recent Developments
Table 56. ImmunoGen Cancer Vaccine Basic Information
Table 57. ImmunoGen Cancer Vaccine Product Overview
Table 58. ImmunoGen Cancer Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. ImmunoGen Business Overview
Table 60. ImmunoGen Cancer Vaccine SWOT Analysis
Table 61. ImmunoGen Recent Developments
Table 62. Inovio Pharmaceuticals Cancer Vaccine Basic Information
Table 63. Inovio Pharmaceuticals Cancer Vaccine Product Overview
Table 64. Inovio Pharmaceuticals Cancer Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Inovio Pharmaceuticals Business Overview
Table 66. Inovio Pharmaceuticals Cancer Vaccine SWOT Analysis
Table 67. Inovio Pharmaceuticals Recent Developments
Table 68. Novartis Cancer Vaccine Basic Information
Table 69. Novartis Cancer Vaccine Product Overview
Table 70. Novartis Cancer Vaccine Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Novartis Business Overview
Table 72. Novartis Cancer Vaccine SWOT Analysis
Table 73. Novartis Recent Developments
Table 74. Global Cancer Vaccine Sales Forecast by Region (K Units)
Table 75. Global Cancer Vaccine Market Size Forecast by Region (M USD)
Table 76. North America Cancer Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 77. North America Cancer Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 78. Europe Cancer Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 79. Europe Cancer Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 80. Asia Pacific Cancer Vaccine Sales Forecast by Region (2022-2028) & (K Units)
Table 81. Asia Pacific Cancer Vaccine Market Size Forecast by Region (2022-2028) & (M USD)
Table 82. South America Cancer Vaccine Sales Forecast by Country (2022-2028) & (K Units)
Table 83. South America Cancer Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 84. Middle East and Africa Cancer Vaccine Consumption Forecast by Country (2022-2028) & (Units)
Table 85. Middle East and Africa Cancer Vaccine Market Size Forecast by Country (2022-2028) & (M USD)
Table 86. Global Cancer Vaccine Sales Forecast by Type (2022-2028) & (K Units)
Table 87. Global Cancer Vaccine Market Size Forecast by Type (2022-2028) & (M USD)
Table 88. Global Cancer Vaccine Price Forecast by Type (2022-2028) & (USD/Unit)
Table 89. Global Cancer Vaccine Sales (K Units) Forecast by Application (2022-2028)
Table 90. Global Cancer Vaccine Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cancer Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Vaccine Market Size (M USD), 2017-2028
Figure 5. Global Cancer Vaccine Market Size (M USD) (2017-2028)
Figure 6. Global Cancer Vaccine Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cancer Vaccine Market Size (M USD) by Country (M USD)
Figure 11. Cancer Vaccine Sales Share by Manufacturers in 2020
Figure 12. Global Cancer Vaccine Revenue Share by Manufacturers in 2020
Figure 13. Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Cancer Vaccine Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cancer Vaccine Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cancer Vaccine Market Share by Type
Figure 18. Sales Market Share of Cancer Vaccine by Type (2017-2022)
Figure 19. Sales Market Share of Cancer Vaccine by Type in 2021
Figure 20. Market Size Share of Cancer Vaccine by Type (2017-2022)
Figure 21. Market Size Market Share of Cancer Vaccine by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Vaccine Market Share by Application
Figure 24. Global Cancer Vaccine Sales Market Share by Application (2017-2022)
Figure 25. Global Cancer Vaccine Sales Market Share by Application in 2021
Figure 26. Global Cancer Vaccine Market Share by Application (2017-2022)
Figure 27. Global Cancer Vaccine Market Share by Application in 2020
Figure 28. Global Cancer Vaccine Sales Growth Rate by Application (2017-2022)
Figure 29. Global Cancer Vaccine Sales Market Share by Region (2017-2022)
Figure 30. North America Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Cancer Vaccine Sales Market Share by Country in 2020
Figure 32. U.S. Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Cancer Vaccine Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Cancer Vaccine Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Cancer Vaccine Sales Market Share by Country in 2020
Figure 37. Germany Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Cancer Vaccine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cancer Vaccine Sales Market Share by Region in 2020
Figure 44. China Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Cancer Vaccine Sales and Growth Rate (K Units)
Figure 50. South America Cancer Vaccine Sales Market Share by Country in 2020
Figure 51. Brazil Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Cancer Vaccine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cancer Vaccine Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Cancer Vaccine Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Cancer Vaccine Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Cancer Vaccine Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Cancer Vaccine Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Cancer Vaccine Market Share Forecast by Type (2022-2028)
Figure 65. Global Cancer Vaccine Sales Forecast by Application (2022-2028)
Figure 66. Global Cancer Vaccine Market Share Forecast by Application (2022-2028)